Pathstone Family Office’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.8M | Buy |
15,955
+10,413
| +188% | +$1.17M | 0.01% | 493 |
|
|
2023
Q2 | $864K | Buy |
5,542
+121
| +2% | +$18.9K | 0.01% | 531 |
|
|
2023
Q1 | $681K | Sell |
5,421
-10,175
| -65% | -$1.28M | 0.01% | 568 |
|
|
2022
Q4 | $5.04M | Buy |
15,596
+2,870
| +23% | +$927K | 0.04% | 279 |
|
|
2022
Q3 | $1.34M | Buy |
12,726
+8,170
| +179% | +$860K | 0.01% | 604 |
|
|
2022
Q2 | $479K | Buy |
4,556
+1,636
| +56% | +$172K | 0.01% | 592 |
|
|
2022
Q1 | $380K | Sell |
2,920
-253
| -8% | -$32.9K | 0.01% | 656 |
|
|
2021
Q4 | $391K | Buy |
3,173
+1,394
| +78% | +$172K | 0.01% | 630 |
|
|
2021
Q3 | $254K | Hold |
1,779
| – | – | 0.01% | 728 |
|
|
2021
Q2 | $278K | Buy |
+1,779
| New | +$278K | 0.01% | 670 |
|
|
2021
Q1 | – | Sell |
-310
| Closed | -$46K | – | 1349 |
|
|
2020
Q4 | $46K | Buy |
310
+114
| +58% | +$16.9K | ﹤0.01% | 525 |
|
|
2020
Q3 | $26K | Hold |
196
| – | – | ﹤0.01% | 445 |
|
|
2020
Q2 | $23K | Hold |
196
| – | – | ﹤0.01% | 409 |
|
|
2020
Q1 | $19K | Hold |
196
| – | – | ﹤0.01% | 424 |
|
|
2019
Q4 | $284K | Sell |
196
-134
| -41% | -$194K | ﹤0.01% | 365 |
|
|
2019
Q3 | $43K | Buy |
+330
| New | +$43K | 0.01% | 293 |
|
|
2019
Q2 | – | Sell |
-196
| Closed | -$24K | – | 923 |
|
|
2019
Q1 | $24K | Buy |
+196
| New | +$24K | ﹤0.01% | 417 |
|
|
2018
Q2 | – | Sell |
-184
| Closed | -$20K | – | 345 |
|
|
2018
Q1 | $20K | Buy |
+184
| New | +$20K | 0.01% | 161 |
|
|
2017
Q2 | – | Sell |
-7
| Closed | -$1K | – | 659 |
|
|
2017
Q1 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 537 |
|